Antipsychotic long-acting injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. This book brings together clinical and research findings on second generation LAIs in a comprehensive volume with chapters written by international experts. INDICE: 1: Chris Abbott Sam Keith: Antipsychotic adherence in schizophrenia; 2: Tim Lambert and David Taylor: Pharmacology of antipsychotic long-acting injections; 3: Peter Haddad and W. Wolfgang Fleischhacker: Safety and adverse effects of antipsychotic long-acting injections; 4: Mark Taylor and Polash Shajahan: First generation (conventional) antipsychotic long-acting injections; 5: Pierre Chue: Risperidone antipsychotic long-acting injection; 6: John Lauriello and Niels Beck: Recently introduced antipsychotic long-acting injections: olanzapine pamoate and paliperidone palmitate; 7: Robin Emsley, Bonga Chiliza, Laila Asmal, Mathias de Fleuriot: Antipsychotic long-acting injections in early intervention services; 8: Maxine Patel: Attitudes to antipsychotic long-acting injections; 9: Mary Jane Tacchi, Jennifer Nendick, Jan Scott: Patient choice and improving the uptake of long-acting injectable medication; 10: Tim Lambert: Prescribing patterns and determinants of use of antipsychotic long-acting injections: an international perspective; 11: Peter Haddad, Tim Lambert and John Lauriello: The role of antipsychotic long-acting Injections in current practice
- ISBN: 978-0-19-958604-2
- Editorial: Oxford University
- Encuadernacion: Rústica
- Páginas: 288
- Fecha Publicación: 21/10/2010
- Nº Volúmenes: 1
- Idioma: Inglés